772 views

Caraco Pharma receives US FDA approval to market paroxetine HCI tabs (PharmaBiz)- About: Anxiety Disorder News

Paroxetine HCl is a psychotropic drug, which is indicated for the treatment of major depressive disorder, panic disorder, obsessive compulsive disorder, social anxiety disorder, generalized anxiety disorder, and posttraumatic stress disorder. According to IMS Data, for the twelve months ended March 2007, paroxetine HCl generic and brand products Paxil had annual sales of approximately $330 million. Movens, Caraco’s chief executive officer, said, “We are pleased to gain this approval as it complements our portfolio and fortifies our product offering by expanding our product line. We plan to market this product to the generic pharmaceutical market immediately. This will bring our total product selection to 34 different products represented by 70 various strengths. read more

Technorati Tags: , , , , , ,



Comments are closed.